Shares of ConvaTec Group PLC (LON:CTEC) have earned an average rating of “Hold” from the ten brokerages that are covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is GBX 245.78 ($3.45).
Several equities research analysts recently commented on the stock. Peel Hunt lowered shares of ConvaTec Group to a “hold” rating and dropped their price objective for the stock from GBX 390 ($5.48) to GBX 250 ($3.51) in a research note on Tuesday, October 17th. Citigroup reiterated a “neutral” rating and issued a GBX 290 ($4.07) target price on shares of ConvaTec Group in a research note on Wednesday, October 11th. Deutsche Bank reiterated a “sell” rating and issued a GBX 180 ($2.53) target price on shares of ConvaTec Group in a research note on Friday, December 1st. Numis Securities upgraded shares of ConvaTec Group to a “reduce” rating and set a GBX 180 ($2.53) target price on the stock in a research note on Wednesday, October 18th. Finally, Credit Suisse Group dropped their target price on shares of ConvaTec Group from GBX 280 ($3.93) to GBX 225 ($3.16) and set a “neutral” rating on the stock in a research note on Tuesday, October 17th.
In other news, insider Ros Rivaz bought 4,908 shares of the company’s stock in a transaction dated Monday, December 4th. The shares were purchased at an average price of GBX 202 ($2.84) per share, for a total transaction of £9,914.16 ($13,922.43).
Shares of ConvaTec Group (LON CTEC) opened at GBX 190.40 ($2.67) on Friday. ConvaTec Group has a 52 week low of GBX 181.40 ($2.55) and a 52 week high of GBX 349.10 ($4.90). The company has a market cap of $3,730.00 and a PE ratio of -1,730.91.
TRADEMARK VIOLATION WARNING: This article was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another publication, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this article can be read at https://www.dispatchtribunal.com/2018/02/04/convatec-group-plc-ctec-given-average-recommendation-of-hold-by-analysts.html.
ConvaTec Group Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.